Drug eluting ocular implant
AssigneeGlaukos Corporation
InventorsDavid S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
Life of this patent
Estimating the term…
Abstract
Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Claims21
(canceled)
A drug delivery ocular implant comprising:
- an implant body;
- a drug coupled with an outer surface of the implant body and configured to be positioned within an anterior chamber of an eye, the drug being a pellet;
- at least one inflow pathway configured to be positioned in the anterior chamber of the eye;
- and
- at least one outflow pathway configured to be positioned in Schlemm's canal.
A drug delivery ocular implant comprising:
- an implant body comprising a first end configured to be positioned in a first part of an eye and a second end configured to be positioned in a second part of the eye, the second part different than the first part;
- and
- a drug coupled with the first end of the implant body and not contained within an outer shell, the drug being a solid.
A method of implanting a drug delivery ocular implant, the method comprising:
- inserting a delivery instrument releasably holding the drug delivery ocular implant into an eye, the drug delivery ocular implant comprising a drug coupled with a first end of an implant body and not contained within an outer shell;
- advancing the delivery instrument through an anterior chamber of the eye towards a trabecular meshwork;
- using the delivery instrument, positioning the drug delivery ocular implant, wherein the first end of the implant body is positioned within an anterior chamber of the eye and the drug is configured to elute into the anterior chamber of the eye;
- releasing the drug delivery ocular implant from the delivery instrument;
- and
- removing the delivery instrument from the eye.
Dependencies are inferred from the claim text.